tDCS for Alcoholism

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Alcoholism+1 MoretDCS - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new intervention to help people with substance use disorder by targeting brain biomarkers that make relapse more likely.

Eligible Conditions
  • Stimulant Abuse
  • Alcoholism

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 months

2 months
Percent of participants with clean drug screens

Trial Safety

Trial Design

2 Treatment Groups

Active tDCS
1 of 2
Sham tDCS
1 of 2

Experimental Treatment

Non-Treatment Group

80 Total Participants · 2 Treatment Groups

Primary Treatment: tDCS · Has Placebo Group · N/A

Active tDCSExperimental Group · 2 Interventions: Cognitive Training, tDCS · Intervention Types: Behavioral, Device
Sham tDCS
Behavioral
PlaceboComparator Group · 1 Intervention: Cognitive Training · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training
2008
Completed Phase 3
~4100
tDCS
2017
Completed Phase 2
~730

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,259 Previous Clinical Trials
1,484,981 Total Patients Enrolled
9 Trials studying Alcoholism
2,105 Patients Enrolled for Alcoholism
Kelvin Lim, MDPrincipal InvestigatorUniversity of Minnesota
2 Previous Clinical Trials
134 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You meet the MINI 7 diagnostic criteria for either stimulant use disorder (SUD) or alcohol use disorder (AUD).